Hyperkalemia and Risk of CKD Progression: A Propensity Score-Matched Analysis
Kidney360
.
2024 Dec 1;5(12):1824-1834.
doi: 10.34067/KID.0000000000000541.
Epub 2024 Aug 9.
Authors
Abiy Agiro
1
,
Erin Cook
2
,
Fan Mu
2
,
Alexandra Greatsinger
3
,
Jingyi Chen
2
,
Angela Zhao
2
,
Elaine Louden
2
,
Ellen Colman
1
,
Pooja Desai
1
,
Glenn M Chertow
4
Affiliations
1
AstraZeneca, Wilmington, Delaware.
2
Analysis Group, Inc., Boston, Massachusetts.
3
Analysis Group, Inc., New York, New York.
4
Stanford University School of Medicine, Stanford, California.
PMID:
39120948
DOI:
10.34067/KID.0000000000000541
No abstract available
Grants and funding
AstraZeneca